{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T20:51:25Z","timestamp":1782852685619,"version":"3.54.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s11060-023-04365-9","type":"journal-article","created":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T15:02:59Z","timestamp":1688655779000},"page":"587-595","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Let\u2019s make size not matter: tumor control and toxicity outcomes of hypofractionated Gamma Knife radiosurgery for large brain metastases"],"prefix":"10.1007","volume":"163","author":[{"given":"Akash","family":"Mishra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Koffler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emel","family":"Calugaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niara","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirisha Devi","family":"Viswanatha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Begley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram","family":"Bajaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuj","family":"Goenka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,6]]},"reference":[{"key":"4365_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nec.2010.08.007","volume":"22","author":"BD Fox","year":"2011","unstructured":"Fox BD, Cheung VJ, Patel AJ et al (2011) Epidemiology of metastatic brain tumors. Neurosurg Clin N Am 22:1\u20136. https:\/\/doi.org\/10.1016\/j.nec.2010.08.007","journal-title":"Neurosurg Clin N Am"},{"key":"4365_CR2","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S0360-3016(99)00507-6","volume":"47","author":"E Shaw","year":"2000","unstructured":"Shaw E, Scott C, Souhami L et al (2000) Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90 \u2013 05. Int J Radiat Oncol 47:291\u2013298. https:\/\/doi.org\/10.1016\/S0360-3016(99)00507-6","journal-title":"Int J Radiat Oncol"},{"key":"4365_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0360-3016(97)00154-5","volume":"39","author":"C Nieder","year":"1997","unstructured":"Nieder C, Berberich W, Schnabel K (1997) Tumor-related prognostic factors for remission of brain metastases after radiotherapy. Int J Radiat Oncol 39:25\u201330. https:\/\/doi.org\/10.1016\/S0360-3016(97)00154-5","journal-title":"Int J Radiat Oncol"},{"key":"4365_CR4","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ijrobp.2011.06.1965","volume":"83","author":"JH Han","year":"2012","unstructured":"Han JH, Kim DG, Chung H-T et al (2012) Radiosurgery for large brain metastases. Int J Radiat Oncol 83:113\u2013120. https:\/\/doi.org\/10.1016\/j.ijrobp.2011.06.1965","journal-title":"Int J Radiat Oncol"},{"key":"4365_CR5","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1001\/jama.2016.9839","volume":"316","author":"PD Brown","year":"2016","unstructured":"Brown PD, Jaeckle K, Ballman KV et al (2016) Effect of Radiosurgery alone vs Radiosurgery with Whole Brain Radiation Therapy on cognitive function in patients with 1 to 3 brain metastases: a Randomized Clinical Trial. JAMA 316:401. https:\/\/doi.org\/10.1001\/jama.2016.9839","journal-title":"JAMA"},{"key":"4365_CR6","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/S1470-2045(09)70263-3","volume":"10","author":"EL Chang","year":"2009","unstructured":"Chang EL, Wefel JS, Hess KR et al (2009) Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 10:1037\u20131044. https:\/\/doi.org\/10.1016\/S1470-2045(09)70263-3","journal-title":"Lancet Oncol"},{"key":"4365_CR7","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.ijrobp.2007.03.048","volume":"68","author":"H Aoyama","year":"2007","unstructured":"Aoyama H, Tago M, Kato N et al (2007) Neurocognitive function of patients with Brain Metastasis who received either whole brain Radiotherapy Plus stereotactic radiosurgery or radiosurgery alone. Int J Radiat Oncol 68:1388\u20131395. https:\/\/doi.org\/10.1016\/j.ijrobp.2007.03.048","journal-title":"Int J Radiat Oncol"},{"key":"4365_CR8","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.ijrobp.2018.10.038","volume":"103","author":"EJ Lehrer","year":"2019","unstructured":"Lehrer EJ, Peterson JL, Zaorsky NG et al (2019) Single versus Multifraction Stereotactic Radiosurgery for large brain metastases: an International Meta-analysis of 24 trials. Int J Radiat Oncol 103:618\u2013630. https:\/\/doi.org\/10.1016\/j.ijrobp.2018.10.038","journal-title":"Int J Radiat Oncol"},{"key":"4365_CR9","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s11060-018-03008-8","volume":"140","author":"AE Dohm","year":"2018","unstructured":"Dohm AE, Hughes R, Wheless W et al (2018) Surgical resection and postoperative radiosurgery versus staged radiosurgery for large brain metastases. J Neurooncol 140:749\u2013756. https:\/\/doi.org\/10.1007\/s11060-018-03008-8","journal-title":"J Neurooncol"},{"key":"4365_CR10","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13014-016-0653-3","volume":"11","author":"P Navarria","year":"2016","unstructured":"Navarria P, Pessina F, Cozzi L et al (2016) Hypo-fractionated stereotactic radiotherapy alone using volumetric modulated arc therapy for patients with single, large brain metastases unsuitable for surgical resection. Radiat Oncol 11:76. https:\/\/doi.org\/10.1186\/s13014-016-0653-3","journal-title":"Radiat Oncol"},{"key":"4365_CR11","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3171\/2016.10.JNS161480","volume":"128","author":"C Tuleasca","year":"2018","unstructured":"Tuleasca C, Negretti L, Faouzi M et al (2018) Radiosurgery in the management of brain metastasis: a retrospective single-center study comparing Gamma Knife and LINAC treatment. J Neurosurg 128:352\u2013361. https:\/\/doi.org\/10.3171\/2016.10.JNS161480","journal-title":"J Neurosurg"},{"key":"4365_CR12","doi-asserted-by":"publisher","first-page":"855","DOI":"10.3171\/2020.7.JNS192210","volume":"135","author":"WR Kennedy","year":"2021","unstructured":"Kennedy WR, DeWees TA, Acharya S et al (2021) Internal dose escalation associated with increased local control for melanoma brain metastases treated with stereotactic radiosurgery. J Neurosurg 135:855\u2013861. https:\/\/doi.org\/10.3171\/2020.7.JNS192210","journal-title":"J Neurosurg"},{"key":"4365_CR13","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3171\/2016.7.GKS16881","volume":"125","author":"P Dong","year":"2016","unstructured":"Dong P, P\u00e9rez-And\u00fajar A, Pinnaduwage D et al (2016) Dosimetric characterization of hypofractionated Gamma Knife radiosurgery of large or complex brain tumors versus linear accelerator\u2013based treatments. J Neurosurg 125:97\u2013103. https:\/\/doi.org\/10.3171\/2016.7.GKS16881","journal-title":"J Neurosurg"},{"key":"4365_CR14","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s11060-022-04115-3","volume":"159","author":"M Yan","year":"2022","unstructured":"Yan M, Holden L, Wang M et al (2022) Gamma knife icon based hypofractionated stereotactic radiosurgery (GKI-HSRS) for brain metastases: impact of dose and volume. J Neurooncol 159:705\u2013712. https:\/\/doi.org\/10.1007\/s11060-022-04115-3","journal-title":"J Neurooncol"},{"key":"4365_CR15","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.13998","author":"JT Mendel","year":"2021","unstructured":"Mendel JT, Schroeder S, Plitt A et al (2021) Expanded Radiosurgery Capabilities utilizing Gamma Knife Icon\u2122. Cureus. https:\/\/doi.org\/10.7759\/cureus.13998","journal-title":"Cureus"},{"key":"4365_CR16","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL et al (2019) The REDCap consortium: building an international community of software platform partners. J Biomed Inform 95:103208. https:\/\/doi.org\/10.1016\/j.jbi.2019.103208","journal-title":"J Biomed Inform"},{"key":"4365_CR17","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3171\/jns.2000.93.supplement_3.0219","volume":"93","author":"I Paddick","year":"2000","unstructured":"Paddick I (2000) A simple scoring ratio to index the conformity of radiosurgical treatment plans: technical note. J Neurosurg 93:219\u2013222. https:\/\/doi.org\/10.3171\/jns.2000.93.supplement_3.0219","journal-title":"J Neurosurg"},{"key":"4365_CR18","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3171\/sup.2006.105.7.194","volume":"105","author":"I Paddick","year":"2006","unstructured":"Paddick I, Lippitz B (2006) A simple dose gradient measurement tool to complement the conformity index. J Neurosurg 105:194\u2013201. https:\/\/doi.org\/10.3171\/sup.2006.105.7.194","journal-title":"J Neurosurg"},{"key":"4365_CR19","doi-asserted-by":"publisher","first-page":"3773","DOI":"10.1200\/JCO.20.01255","volume":"38","author":"PW Sperduto","year":"2020","unstructured":"Sperduto PW, Mesko S, Li J et al (2020) Survival in patients with brain metastases: Summary Report on the updated diagnosis-specific graded Prognostic Assessment and Definition of the eligibility quotient. J Clin Oncol 38:3773\u20133784. https:\/\/doi.org\/10.1200\/JCO.20.01255","journal-title":"J Clin Oncol"},{"key":"4365_CR20","doi-asserted-by":"publisher","first-page":"e270","DOI":"10.1016\/S1470-2045(15)70057-4","volume":"16","author":"NU Lin","year":"2015","unstructured":"Lin NU, Lee EQ, Aoyama H et al (2015) Response assessment criteria for brain metastases: proposal from the RANO group. Lancet Oncol 16:e270\u2013e278. https:\/\/doi.org\/10.1016\/S1470-2045(15)70057-4","journal-title":"Lancet Oncol"},{"key":"4365_CR21","unstructured":"U.S Department of Health and Human Services Common terminology criteria for adverse events (CTCAE)"},{"key":"4365_CR22","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/j.ijrobp.2016.03.013","volume":"95","author":"G Minniti","year":"2016","unstructured":"Minniti G, Scaringi C, Paolini S et al (2016) Single-fraction Versus Multifraction (3 \u00d7 9 gy) stereotactic radiosurgery for large (> 2\u00a0cm) brain metastases: a comparative analysis of local control and risk of Radiation-Induced Brain Necrosis. Int J Radiat Oncol 95:1142\u20131148. https:\/\/doi.org\/10.1016\/j.ijrobp.2016.03.013","journal-title":"Int J Radiat Oncol"},{"key":"4365_CR23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10585-020-10068-6","volume":"38","author":"Y Samanci","year":"2021","unstructured":"Samanci Y, Sisman U, Altintas A et al (2021) Hypofractionated frameless gamma knife radiosurgery for large metastatic brain tumors. Clin Exp Metastasis 38:31\u201346. https:\/\/doi.org\/10.1007\/s10585-020-10068-6","journal-title":"Clin Exp Metastasis"},{"key":"4365_CR24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11060-021-03805-8","volume":"154","author":"EJ Lee","year":"2021","unstructured":"Lee EJ, Choi K-S, Park ES, Cho YH (2021) Single- and hypofractionated stereotactic radiosurgery for large (> 2\u00a0cm) brain metastases: a systematic review. J Neurooncol 154:25\u201334. https:\/\/doi.org\/10.1007\/s11060-021-03805-8","journal-title":"J Neurooncol"},{"key":"4365_CR25","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.3346\/jkms.2019.34.e57","volume":"34","author":"HR Park","year":"2019","unstructured":"Park HR, Park K-W, Lee JM et al (2019) Frameless Fractionated Gamma Knife Radiosurgery with ICON\u2122 for large metastatic brain tumors. J Korean Med Sci 34:e57. https:\/\/doi.org\/10.3346\/jkms.2019.34.e57","journal-title":"J Korean Med Sci"},{"key":"4365_CR26","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.clon.2013.11.027","volume":"26","author":"T Murai","year":"2014","unstructured":"Murai T, Ogino H, Manabe Y et al (2014) Fractionated stereotactic radiotherapy using CyberKnife for the treatment of large brain metastases: a dose escalation study. Clin Oncol 26:151\u2013158. https:\/\/doi.org\/10.1016\/j.clon.2013.11.027","journal-title":"Clin Oncol"},{"key":"4365_CR27","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ijrobp.2020.08.013","volume":"110","author":"MT Milano","year":"2021","unstructured":"Milano MT, Grimm J, Niemierko A et al (2021) Single- and multifraction stereotactic radiosurgery Dose\/Volume tolerances of the brain. Int J Radiat Oncol 110:68\u201386. https:\/\/doi.org\/10.1016\/j.ijrobp.2020.08.013","journal-title":"Int J Radiat Oncol"},{"key":"4365_CR28","doi-asserted-by":"publisher","first-page":"379","DOI":"10.3389\/fonc.2018.00379","volume":"8","author":"GL Masucci","year":"2018","unstructured":"Masucci GL (2018) Hypofractionated Radiation Therapy for large brain metastases. Front Oncol 8:379. https:\/\/doi.org\/10.3389\/fonc.2018.00379","journal-title":"Front Oncol"},{"key":"4365_CR29","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.ijrobp.2020.06.057","volume":"108","author":"CA Helis","year":"2020","unstructured":"Helis CA, Hughes RT, Glenn CW et al (2020) Predictors of adverse Radiation Effect in Brain Metastasis Patients treated with stereotactic radiosurgery and Immune checkpoint inhibitor therapy. Int J Radiat Oncol 108:295\u2013303. https:\/\/doi.org\/10.1016\/j.ijrobp.2020.06.057","journal-title":"Int J Radiat Oncol"},{"key":"4365_CR30","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s10555-020-09949-9","volume":"40","author":"P-Y Borius","year":"2021","unstructured":"Borius P-Y, R\u00e9gis J, Carpentier A et al (2021) Safety of radiosurgery concurrent with systemic therapy (chemotherapy, targeted therapy, and\/or immunotherapy) in brain metastases: a systematic review. Cancer Metastasis Rev 40:341\u2013354. https:\/\/doi.org\/10.1007\/s10555-020-09949-9","journal-title":"Cancer Metastasis Rev"},{"key":"4365_CR31","doi-asserted-by":"publisher","first-page":"3682","DOI":"10.3390\/cancers13153682","volume":"13","author":"R Tonse","year":"2021","unstructured":"Tonse R, Tom MC, Mehta MP et al (2021) Integration of systemic therapy and stereotactic radiosurgery for Brain Metastases. Cancers 13:3682. https:\/\/doi.org\/10.3390\/cancers13153682","journal-title":"Cancers"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-023-04365-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-023-04365-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-023-04365-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T14:09:52Z","timestamp":1690898992000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-023-04365-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["4365"],"URL":"https:\/\/doi.org\/10.1007\/s11060-023-04365-9","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"3 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The database utilized for the current study was approved by the Northwell Health Institutional Review Board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"This retrospective database analysis did not require patient consent to participate as determined by the Northwell Health Institutional Review Board.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}